Centers for Disease Control and Prevention-医療機器分野:企業M&A・提携分析

◆英語タイトル:Centers for Disease Control and Prevention - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011492
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Centers for Disease Control and Prevention (CDC), a subsidiary of US Department of Health and Human Services is a public health institute that offers health, safety and security threat management solutions. The institute provides health information to fight diseases and support communities from expensive and dangerous health threats. It offers services in the areas of attention-deficit hyperactivity disorder, cancer, diabetes, heart disease, flu, and sexually transmitted diseases. CDC also offers laboratory safety services by conducting scientific research. The institute has collaboration with schools and universities, business, labor, public health associations, industries, international health organizations and others to prevent human health. CDC is headquartered in Atlanta, Georgia, the US.

Centers for Disease Control and Prevention – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Centers for Disease Control and Prevention, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Centers for Disease Control and Prevention, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Centers for Disease Control and Prevention, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Centers for Disease Control and Prevention, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Centers for Disease Control and Prevention, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Centers for Disease Control and Prevention, Medical Equipment, Deal Details 10
Partnerships 10
Centers for Disease Control and Prevention Enters into Research Agreement with Edico Genome 10
Accelerate Diagnostics Enters into Co-Development Agreement with Centers for Disease Control and Prevention 11
Bruker Enters Into Research Agreement With Special Bacteriology Reference Laboratory 12
Centers for Disease Control and Prevention – Key Competitors 13
Centers for Disease Control and Prevention – Key Employees 14
Centers for Disease Control and Prevention – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Legal and Regulatory 16
Jan 04, 2017: New Antimicrobial Stewardship Standard issued for US hospitals to fight antimicrobial resistance 16
Government and Public Interest 17
May 05, 2017: CDC updates guidance on interpretation of Zika testing results for pregnant women 17
Nov 29, 2016: Open-heart surgery patients notified of potential infection risk 18
Product News 19
Dec 05, 2017: Screening for Critical Congenital Heart Disease at Birth Saves Lives 19
Jul 19, 2016: New system uses electrical conductivity to measure dry blood samples used in infant HIV screening, testing for metabolic disorders 20
Jun 22, 2016: U.S. healthcare facilities have capacity to meet colorectal cancer screening goals 21
May 18, 2016: CDC expanding groundbreaking disease identification tool 22
May 05, 2016: The Parkview Mirro Center for Research and Innovation Initiates Study to Demonstrate Value of Personalized Patient Engagement for Those Suffering from Heart Failure 23
Apr 14, 2016: Increased use of type of diagnostic test poses challenge to tracking of foodborne illness 24
02/26/2016: New CDC Laboratory Test for Zika Virus Authorized for Emergency Use by FDA 26
Product Approvals 27
Feb 26, 2016: New CDC Laboratory Test for Zika Virus Authorized for Emergency Use by FDA 27
Other Significant Developments 28
Oct 09, 2017: N.J. Perinatal Collaborative Receives CDC Grant 28
Mar 09, 2017: NTT DATA Awarded Contract by the Centers for Disease Control and Prevention 29
Apr 28, 2016: ICF International awarded $14 million in task orders by Centers for Disease Control and Prevention 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Centers for Disease Control and Prevention, Medical Equipment, Key Facts 2
Centers for Disease Control and Prevention, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Centers for Disease Control and Prevention, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Centers for Disease Control and Prevention, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Centers for Disease Control and Prevention, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Centers for Disease Control and Prevention, Deals By Market, 2011 to YTD 2017 8
Centers for Disease Control and Prevention, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Centers for Disease Control and Prevention Enters into Research Agreement with Edico Genome 10
Accelerate Diagnostics Enters into Co-Development Agreement with Centers for Disease Control and Prevention 11
Bruker Enters Into Research Agreement With Special Bacteriology Reference Laboratory 12
Centers for Disease Control and Prevention, Key Competitors 13
Centers for Disease Control and Prevention, Key Employees 14
Centers for Disease Control and Prevention, Subsidiaries 15

★海外企業調査レポート[Centers for Disease Control and Prevention-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aviva Poland:企業の戦略・SWOT・財務情報
    Aviva Poland - Strategy, SWOT and Corporate Finance Report Summary Aviva Poland - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Protagen AG:企業の製品パイプライン分析2018
    Summary Protagen AG (Protagen) is a medical device company that develops molecular diagnostic and companion diagnostic test equipment. The company’s products include multilisa SSC, multilisa SLE and multilisa RA. It provides products for autoimmune diseases such as rheumatoid arthritis, neuromyeliti …
  • Inditex SA (ITX):企業の財務・戦略的SWOT分析
    Inditex SA (ITX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Universiteit Utrecht-製薬・医療分野:企業M&A・提携分析
    Summary Universiteit Utrecht (Universiteit Utrecht) is a research university that offers education programs. The university offers bachelors, master's, honor education, education for professionals, online education, training and other education courses. Its research areas include earth and sustainab …
  • Arch Pharmalabs Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Arch Pharmalabs Ltd (Arch Pharmalabs) is a healthcare products company that offers pharmaceutical ingredients. The company manufactures, develops and markets active APIs and intermediates to innovator and generic pharmaceutical players. It offers products such as docetaxel anhydrous and trih …
  • Bank of Panhsin:企業の戦略・SWOT・財務情報
    Bank of Panhsin - Strategy, SWOT and Corporate Finance Report Summary Bank of Panhsin - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Grupa Azoty SA (ATT):企業の財務・戦略的SWOT分析
    Grupa Azoty SA (ATT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • SunTrust Wealth Management:企業の戦略・SWOT・財務情報
    SunTrust Wealth Management - Strategy, SWOT and Corporate Finance Report Summary SunTrust Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • SSA Marine Inc:企業の戦略的SWOT分析
    SSA Marine Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Pioneer Natural Resources Co (PXD):企業の財務・戦略的SWOT分析
    Pioneer Natural Resources Co (PXD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Omnicell Inc (OMCL):企業の財務・戦略的SWOT分析
    Omnicell Inc (OMCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • China Merchants Bank Co., Ltd.:企業のM&A・事業提携・投資動向
    China Merchants Bank Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Merchants Bank Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • UGI Corporation (UGI)-石油・ガス分野:企業M&A・提携分析
    Summary UGI Corporation (UGI) is a holding company providing energy products and services. Through a network of subsidiaries, the company stores, transports, distributes and markets energy products and related services. It serves as a domestic and international retail distributor of propane and buta …
  • Ezaki Glico Co Ltd:企業の戦略・SWOT・財務分析
    Ezaki Glico Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Ezaki Glico Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Business Development Bank of Canada:企業のM&A・事業提携・投資動向
    Business Development Bank of Canada - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Business Development Bank of Canada Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on …
  • Ems-Chemie Holding AG (EMSN):企業の財務・戦略的SWOT分析
    Summary Ems-Chemie Holding AG (Ems-Chemie), a subsidiary of Emesta Holding AG, is a chemical company. The company manufactures and markets high performance polymers and specialty chemicals. Its products include bonding products, polyamides, damping systems, sealants, and coating products. Ems-Chemie …
  • Arthur J. Gallagher & Co:企業の戦略・SWOT・財務情報
    Arthur J. Gallagher & Co - Strategy, SWOT and Corporate Finance Report Summary Arthur J. Gallagher & Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Wellington Management Company LLP:企業の戦略・SWOT・財務情報
    Wellington Management Company LLP - Strategy, SWOT and Corporate Finance Report Summary Wellington Management Company LLP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • LM Wind Power Holding AS:企業の戦略的SWOT分析
    LM Wind Power Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Rhenovia Pharma Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Rhenovia Pharma Ltd (Rhenovia) is a biotechnology company that provides solutions for the treatment of Alzheimers disease and other central nervous system diseases. The company offers studies to academic research groups and industries based on biosimulation technology, which is a computation …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆